ANEBULO PHARMACEUTICALS, INC. Increase (Decrease) in Deferred Charges
ANEBULO PHARMACEUTICALS, INC. (ANEB) reported Increase (Decrease) in Deferred Charges of $392.73 thousand for the 9-month period ending 2021-03-31, per its 10-Q filed 2021-06-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2021-06-21
- 2021-03-31: Increase (Decrease) in Deferred Charges 9 month $392.73K.
| Period end | Increase (Decrease) in Deferred Charges 9 month |
|---|---|
| 2021-03-31 | $392.73K 10-Q · filed 2021-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |